-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Agios Pharmaceuticals, Raises Price Target to $34

Benzinga·08/07/2026 15:36:36
Listen to the news
JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and raises the price target from $31 to $34.